ERBB2 and colorectal carcinoma: Established scoring systems for the evaluation of ERBB2 status in CRC, like the HERACLES criteria, rely on immunohistochemical stains (IHC) for quantifying expression and fluorescence in situ hybridization (FISH) for quantifying gene amplification [9].